RNA editing has picked up steam in recent years as a potentially safer alternative to gene editing to treat genetic diseases.

On a mission to overcome the dosing challenges posed by radiotherapy, French nanotherapy company Nanobiotix is developing a ...

As Shift Bioscience raises $16 million in seed funding, delve into the field of cellular reprogramming to tackle age-related ...

The promise of AI in biotech and in oncology is vast. Lately, AI utilization in the health industry has seen signs of a market correction to the point where we wondered whether we were in an AI bubble ...

The biopharma industry is always in need of talented minds to take promising pipelines to the clinic and beyond. A good biotech entrepreneur is able to cope with change and failure and has proven ...

JAK inhibitors have gained particular attention in the inflammation and immunology (I&I) space, an area that has brought in a wave of investment in recent times. Pharma giants such as Pfizer and ...

Discover advances in epilepsy treatments, innovative solutions for seizure freedom, and challenges in integrating new ...

Discover Booster Therapeutics' novel 20S proteasome activation approach to neurodegenerative diseases as it launches with $15 ...

Find out more about five biomimicry companies harnessing nature’s wisdom to create drug candidates for the benefit of human ...